Recombinant Prostate Specific Antigen antibody (full length)

Catalog No. ABIN7878867

The Rabbit Monoclonal anti-Prostate Specific Antigen antibody is suitable to detect Prostate Specific Antigen in samples from Human. It has been validated for IHC (p).

Quick Overview for Recombinant Prostate Specific Antigen antibody (full length) (ABIN7878867)

Target: Prostate Specific Antigen (PSA)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Rabbit

Clonality: Monoclonal

Conjugate: This Prostate Specific Antigen antibody is un-conjugated

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: KLK3-4551R

Product Details anti-Prostate Specific Antigen Antibody

Binding Specificity: full length

Purpose: Recombinant PSA Antibody / Prostate Specific Antigen

Purification: Protein A affinity chromatography

Immunogen: Recombinant full-length human KLK3/PSA protein was used as the immunogen for the recombinant PSA antibody.

Isotype: IgG

Application Details

Application Notes: Optimal dilution of the recombinant PSA antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store the recombinant PSA antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Target Details for Prostate Specific Antigen

Target: Prostate Specific Antigen (PSA)

Alternative Name: PSA

Background: Recognizes a single protein of 33-34 kDa, identified as the prostate specific antigen (PSA). This MAb is highly specific to PSA and stains prostatic secretory and ductal epithelium in both normal and neoplastic tissues. PSA is a chymotrypsin-like serine protease (kallikrein family) exclusively produced by the prostate epithelium, and abundant in seminal fluid. PSA can be detected in the sera of patients with prostatic carcinoma. It is predominantly complexed to a liver-derived serine protease inhibitor, alpha-1-antichymotrypsin (ACT). A higher proportion of serum PSA is complexed to ACT in prostate cancer than in benign prostate hyperplasia. This mAb makes an excellent pair with clone 1A7G6B6 for PSA tests.

UniProt: P07288

Pathways: Complement System